DELCATH SYSTEMS, INC.

Develops targeted chemotherapy delivery systems for treating primary and metastatic liver cancers.

DCTH | NDAQ

Overview

Corporate Details

ISIN(s):: US24661P8077
LEI:
Country:: United States of America
Address:: 566 QUEENSBURY AVENUE, 12804 QUEENSBURY
Website:: https://delcath.com/
Sector:: Manufacturing
Industry:: Manufacture of medical and dental instruments and supplies

Description

Delcath Systems, Inc. is a commercial-stage, interventional oncology company focused on treating primary and metastatic liver cancers. The company develops and commercializes specialty pharmaceutical and medical device products based on its proprietary percutaneous hepatic perfusion (PHP) technology. This minimally-invasive procedure is designed to deliver high-dose chemotherapy directly to the liver while controlling systemic side effects. Its flagship products are the HEPZATO KIT™, recently FDA-approved in the U.S. for treating metastatic uveal melanoma, and the CHEMOSAT® Hepatic Delivery System, a medical device available in Europe. Delcath aims to provide targeted, minimally-invasive treatment options for patients with liver-dominant cancers.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all DELCATH SYSTEMS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DELCATH SYSTEMS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for DELCATH SYSTEMS, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Glycorex Transplantation AB Develops devices that remove blood antibodies, enabling organ transplants across blood groups.	Sweden	GTAB
GN Store Nord Develops hearing, audio, and video solutions for medical, professional, and consumer markets.	Denmark	GN
Gour Medical Develops diagnostic solutions and medical devices for the veterinary sector.	France	MLGML
Green Cross Medical Science Corporation Develops diagnostic reagents, blood glucose monitors, blood bags, and hemodialysis fluids.	South Korea	142280
Guerbet Offers medical imaging solutions, from contrast agents to AI, for healthcare professionals.	France	GBT
Gvs Manufactures advanced filters & components for highly regulated MedTech, Life Sciences, and Safety.	Italy	GVS
HAEMONETICS CORP Provides blood management solutions for plasma collection centers, hospitals, and surgical suites.	United States of America	HAE
HANS BIOMED CORPORATION Develops tissue grafts, breast implants & lifting threads for global regenerative/aesthetic surgery.	South Korea	042520
HASS Corp. Manufactures all-ceramic and glass-ceramic materials for dental CAD/CAM prosthetics.	South Korea	450330
HealthBeacon SHA A smart sharps bin system improving adherence for patients using injectable medications at home.	Ireland	HBCN